Learn More
MEDILUMINE INC MediLumine Inc. Bradykinin B1R Agonist, 1 mg
Supplier: MEDILUMINE INC B1111
Metabolically stable agonist of Bradykinin B1 receptor for in vitro & in vivo preclinical research.Temporary permeabilization of the blood-tumour barrier in brain cancer, biomarker research in fields of diabetes and alzheimer’s research.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.